Neuroendocrine differentiation in non-small cell lung carcinomas

In Vivo. 2000 Jan-Feb;14(1):109-14.

Abstract

The immunohistochemical expression of ten neuroendocrine and neural differentiation-related antigens in 200 specimens from patients with surgically resected non-small cell lung carcinomas were evaluated. Poorly differentiated adenocarcinomas and undifferentiated large cell carcinomas showed the highest percentage of positive samples (30%-60%) for the markers evaluated with diffuse and intense immunostaining. Poorly differentiated squamous carcinomas bronchioalveolar adenocarcinomas, and giant cell carcinomas showed a lower percentage of positive samples (20%) with moderate immunostaining. Well differentiated tumors were very rarely positive for the neuroendocrine markers. It is concluded that neoplasms positive for the neuroendocrine markers can be considered as non-small cell carcinoma with neuroendocrine features, even if they do not have the histological appearance of neuroendocrine lung neoplasms.

MeSH terms

  • Adrenocorticotropic Hormone / analysis
  • Bombesin / analysis
  • CD57 Antigens / analysis
  • Calcitonin / analysis
  • Carcinoma, Neuroendocrine / metabolism*
  • Carcinoma, Neuroendocrine / pathology
  • Carcinoma, Non-Small-Cell Lung / metabolism*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Cell Differentiation
  • Chromogranin A
  • Chromogranins / analysis
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / pathology
  • Neurofilament Proteins / analysis
  • Phosphopyruvate Hydratase / analysis
  • Serotonin / analysis
  • Vasopressins / analysis
  • Vimentin / analysis

Substances

  • CD57 Antigens
  • Chromogranin A
  • Chromogranins
  • Neurofilament Proteins
  • Vimentin
  • Vasopressins
  • Serotonin
  • Adrenocorticotropic Hormone
  • Calcitonin
  • Phosphopyruvate Hydratase
  • Bombesin